Skip to main content
OpenTrials

Clinical trial condition

Gastroesophageal-junction Cancer

Explore clinical trials studying Gastroesophageal-junction Cancer. Study availability and eligibility vary by location and protocol.

19 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Gastroesophageal-junction Cancer trial results

Active, Not Recruiting

Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal Junction

NCT05480384

Conditions
Adenocarcinoma Of Esophagus, Digestive System Diseases, Digestive System Neoplasms, +11 more
Locations
  • Weill Cornell Medicine/New York-Presbyterian New York, United States
  • Lifespan Cancer Institute Providence, Rhode Island, United States
View Trial Details
Active, Not Recruiting

Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors

NCT05858736

Conditions
Adenocarcinoma, Adnexal Diseases, Anal Cancer, +85 more
Locations
  • St. Vincent's Private Hospital Darlinghurst, New South Wales, Australia
  • Mater Misericordiae Ltd. Brisbane, Queensland, Australia
  • Tasman Oncology Research Southport, Queensland, Australia
  • Cancer Research SA Adelaide, South Australia, Australia
View Trial Details
Active, Not Recruiting

A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors

NCT04396821

Conditions
Advanced Cancer, Digestive System Diseases, Digestive System Neoplasms, +13 more
Locations
  • Banner MD Anderson Gilbert, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
  • Yale University New Haven, Connecticut, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma

NCT05539430

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +16 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • John Theurer Cancer Center at HackensackUMC Hackensack, New Jersey, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
View Trial Details
Active, Not Recruiting

Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors

NCT06714617

Conditions
Adnexal Diseases, Breast Cancer Stage III, Breast Diseases, +48 more
Locations
  • SCRI-Denver HealthOne Denver, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • SCRI-Florida Cancer Center Specialists Lake Mary Lake Mary, Florida, United States
  • Hematology Oncology Associates of the Treasure Cost Port Saint Lucie, Florida, United States
View Trial Details

Related conditions